Medico Remedies Ltd.

•

medicoremediesindia.com / www.medicoremediesindia.net / www.tabletandcapsules.comBSE: 540937NSE: MEDICO

Market Cap₹ 328 Cr.

Current Price

High / Low₹ 57 / 30

Stock P/E23.8

Book Value₹ 9

Price to Book6.92

Dividend Yield0.00 %

ROCE21.7 %

ROE17.6 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 44.0% CAGR over last 5 years
Company has a healthy return on capital (ROCE) of 21.8%
Latest quarter profit grew 38.4% YoY, showing strong momentum
Company comfortably covers its interest (12.7x coverage)
Company generates healthy free cash flow
Company maintains a comfortable, low leverage position

CONS

Promoter holding has decreased over last 2 years: -12.0pp
Total debt has risen sharply - up 104.9% year on year
Stock is trading at 6.9x its book value
Growth is decelerating - 3Y profit CAGR (28.0%) trails the 5Y trend (44.0%)
Rich enterprise valuation - EV/EBITDA of 25.2x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1904.00	37.77	456833.38	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9245.00	83.91	245425.70	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4924.70	85.89	187319.76	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1135.00	25.09	113216.68	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1389.00	33.29	112211.54	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1872.15	92.52	101154.55	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2135.00	17.66	97626.26	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2345.00	47.42	96859.07	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1155.00	29.92	96405.53	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1627.00	25.22	93613.98	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2458.80	38.60	69393.40	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	MEDICO	39.58	23.77	328.45	0.00	2.52	38.35	69.40	81.44	21.65	4.75

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	31	42	30	41	31	39	39	41	38	53	59	57	69
	29	39	27	37	28	37	36	35	35	50	54	50	67
Operating Profit	2	3	3	5	3	2	3	7	3	3	4	7	2
OPM %	7.82%	7.27%	9.17%	11.23%	9.12%	6.12%	7.88%	16.13%	7.37%	5.17%	7.38%	12.59%	3.13%
	0	1	0	1	0	1	1	0	1	2	1	3	1
Interest	0	0	0	0	0	0	0	0	0	0	0	1	0
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1
Profit before Tax	2	3	2	4	2	2	4	6	2	3	4	8	3
Tax %	29.79%	22.93%	30.10%	27.06%	27.52%	27.23%	25.14%	23.86%	25.51%	26.22%	25.07%	29.57%	24.62%
Net Profit	1	2	1	3	2	2	3	4	2	3	3	6	3
	0.16	0.29	0.17	0.37	0.19	0.19	0.32	0.52	0.22	0.31	0.35	0.71	0.30

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	67	54	61	98	89	122	121	140	145	151	238
	63	50	58	95	86	117	114	131	132	137	221
Operating Profit	4	4	3	3	3	5	7	9	13	14	16
OPM %	5.49%	7.37%	5.70%	2.83%	3.21%	4.28%	6.06%	6.75%	8.91%	9.55%	6.89%
	0	0	1	2	2	1	2	4	2	3	6
Interest	1	1	2	1	1	1	1	1	1	1	2
Depreciation	1	1	1	2	2	2	2	3	3	3	3
Profit before Tax	2	2	2	2	2	4	6	10	11	14	19
Tax %	39.62%	3.56%	34.84%	27.81%	26.40%	30.00%	25.78%	28.29%	26.86%	25.26%	27.17%
Net Profit	1	2	1	2	2	3	5	7	8	10	14
EPS	0.00	0.00	0.00	0.00	3.93	6.25	2.90	0.87	1.00	1.22	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 11%
5 Years:: 11%
3 Years:: 8%

COMPOUNDED PROFIT GROWTH

10 Years:: 29%
5 Years:: 44%
3 Years:: 28%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: -20%
1 Year:: 1%

RETURN ON EQUITY

10 Years:: 11%
5 Years:: 15%
3 Years:: 18%
Last Year:: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	2	3	4	4	4	4	17	17	17	17
	13	13	23	24	26	28	20	27	36	46
	14	19	12	13	12	13	12	10	8	14
Trade Payables	15	12	18	33	26	25	27	31	32	35
	1	1	3	3	7	5	3	5	7	10
Total Liabilities	46	48	59	76	75	76	79	89	98	122
	7	7	7	12	13	15	18	22	21	21
Capital Work in Progress	0	3	4	1	2	0	0	0	0	0
	1	0	0	0	0	1	0	1	2	2
	9	10	15	16	18	15	18	20	16	27
	0	0	0	0	0	0	0	0	50	57
Cash & Bank	1	1	1	1	1	3	2	1	0	1
	28	28	32	46	41	42	40	45	9	13
Total Assets	46	48	59	76	75	76	79	89	98	122

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-3	-2	6	6	2	-10	8	11	2	5
Cash from Investing	0	-3	-5	-4	-3	-17	-2	-7	-3	-3
Cash from Financing	2	6	-1	-1	3	18	-6	-2	-0	-1
	-1	-0	-0	-0	0	-10	-2	-0	-1	1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	7.06	5.09	2.94	3.78	3.93	6.24	2.90	0.87	1.00	1.22
Book Value (₹)	92.15	51.16	64.27	68.05	71.98	78.22	22.04	5.28	6.31	7.53
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	0.36	0.42	0.27	0.37	0.40	0.51	0.85	1.20	1.35	1.58
PROFITABILITY
Operating Margin %	5.85%	7.64%	7.11%	4.78%	5.57%	5.12%	7.74%	9.66%	8.91%	9.55%
Net Margin %	1.69%	2.85%	1.98%	1.61%	1.84%	2.12%	3.98%	5.16%	5.72%	6.69%
ROE %	7.97%	10.47%	5.67%	5.72%	5.61%	8.31%	13.94%	18.01%	17.23%	17.58%
ROCE %	10.86%	9.39%	9.05%	7.79%	7.66%	10.13%	15.09%	21.88%	21.90%	21.65%
	2.78%	3.47%	2.26%	2.31%	2.15%	3.43%	6.24%	8.63%	8.85%	9.18%
EFFICIENCY
Debtor Days	74	120	104	86	109	77	87	86	108	129
Inventory Days	47	62	74	58	71	49	49	49	45	52
Payable Days	98	169	160	135	187	119	135	120	119	128
	23	12	18	9	-8	6	1	16	34	53
FINANCIAL HEALTH
Debt to Equity (x)	0.94x	1.18x	0.47x	0.48x	0.46x	0.46x	0.29x	0.18x	0.13x	0.22x
Interest Coverage (x)	3.21x	2.27x	2.23x	3.22x	3.09x	5.02x	10.79x	14.52x	14.76x	12.66x
	1.39x	1.81x	1.51x	1.30x	1.40x	1.54x	1.49x	1.53x	1.70x	1.68x
GROWTH
Revenue Growth %	30.78%	-18.39%	12.14%	60.08%	-9.27%	38.08%	-1.12%	16.04%	3.19%	4.15%
Operating Profit Growth %	29.19%	12.07%	0.56%	6.16%	5.85%	26.98%	49.34%	44.89%	10.85%	17.65%
Net Profit Growth %	42.66%	44.10%	-25.06%	28.68%	3.84%	58.86%	85.79%	50.49%	14.49%	21.74%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.50%	21.74%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	49.32x	42.83x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	7.81x	6.92x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	27.63x	25.16x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	73.34	73.34	66.83	63.79	62.59	61.38	61.38	61.38	61.38
	0.22	0.00	0.39	0.11	0.07	0.30	0.49	0.03	0.08
	0.97	0.97	0.78	0.01	0.01	0.01	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	25.47	25.47	32.00	36.08	37.33	38.30	38.13	38.59	38.54

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-29

General Updates

2026-08-29 - Medico Remedies Limited has informed the Exchange about Book Closure Dates.

2026-08-29

Shareholders meeting

2026-08-29 - Medico Remedies Limited has informed the Exchange regarding Notice of undefined to be held on September 22, 2026

2026-08-13

Outcome of Board Meeting

2026-08-13 - Medico Remedies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-05

Bagging/Receiving of orders/contracts

2026-08-05 - Medico Remedies Limited has informed the Exchange about Bagging/Receiving of orders/contracts

2026-08-03

Price movement

2026-08-03 - Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

2026-06-30

Trading Window

2026-06-30 - Medico Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-06-29

Credit Rating

2026-06-29 - Medico Remedies Limited has informed the Exchange about Credit Rating

2026-06-03

Action(s) taken or orders passed

2026-06-03 - Medico Remedies Limited has informed the Exchange about Action(s) taken or orders passed

2026-06-01

Disclosure under SEBI Takeover Regulations

2026-06-01 - Harshit Mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

News

Recent coverage and analyst commentary for MEDICO

Loading news…

🤖

AI Stock Analyst

Medico Remedies Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account